Brasil Pharma SA (BPHA3) Decline -0.59% on Oct 21

October 21, 2017 - By Linda Rogers

Shares of Brasil Pharma SA (BVMF:BPHA3) last traded at 5.08, representing a move of -0.59%, or -0.03 per share, on volume of 4,200 shares. After opening the trading day at 5.14, shares of Brasil Pharma SA traded in a close range. Brasil Pharma SA currently has a total float of 113.08M shares and on average sees 93,680 shares exchange hands each day. The stock now has a 52-week low of 4.41 and high of 10.24.

BM&F Bovespa: A Powerful South American Stock Exchange

The Brazilian Mercantile and Futures (BM&F) Bovespa is one of the oldest stock exchanges in the world, serving as Brazil’s primary stock exchange since August 23, 1890. It had always been a public entity tightly overseen by the government until its privatization in 2007. As one of the biggest stock exchanges in the world, the BM&F Bovespa has global offices located in Shanghai, London, and New York City (NYC). Brasil Pharma SA and other companies are included in its lists.

Getting to Know the Brazilian Equity Market

The BM&F Bovespa had first adopted electronic trading in 1972. The Mega Bolsa, an optimized electronic trading system, had replaced the first one in 1997.

During the late 1970s, the BM&F Bovespa had also implemented the Private System of Telephone Trading, a new trading system that allows investors and brokers alike to conduct transactions via telephone calls.

In 1999, a convenient online trading system had finally been adopted with the launch of the Home Broker. Consequently, investors can buy and sell BM&F Bovespa stocks right from the comfort of their dwellings. It made easier the work of Brasil Pharma SA company there.

The pre-market trading on the BM&F Bovespa opens at 9:45 a.m. and closes at 10:00 a.m; the regular trading opens at 10:00 a.m. and closes at 5:30 p.m.; and the post-market trading opens at 6:00 p.m. and closes at 7:30 p.m. These long trading hours give international investors in particular the flexible opportunity to trade on the BM&F Bovespa wherever they are in the world. To sum it up, time zone differences cannot be potential sources of dilemma.

Meanwhile, the Ibovespa Brasil Sao Paulo Stock Exchange Index, the benchmark Brazilian index, had been formed in 1968 as the oldest index weighting the stocks listed on the BM&F Bovespa. Measuring the top 50 stocks listed on the BM&F Bovespa based on market capitalization, it is surely one of the most influential indices in the South American economy.

Reviewing of the components of the Ibovespa occur quarterly to drop those that had fallen short of competent representation and to add those that qualify for inclusion. For a stock to be eligible for inclusion, it must have been listed on the BM&F Bovespa for not less than 12 months and at least 80% of its shares must be actively traded.

By the Numbers

The biggest daily trading volume of nearly $15 billion on the BM&F Bovespa had been posted on August 17, 2011. Today, there are more than 450 stocks listed on it.

The Ibovespa had hit an all-time high of 73,516 points on May 20, 2008. The compelling performance during that time is mainly attributed to a positive inflation guidance by the government. A few days later on May 29, 2008, the Ibovespa had hit its all-time best intraday high of 73,920 points.

It is highly recommended for investors to bet on the growing Brazilian economy. The best way to do so is to trade on the BM&F Bovespa, one of the world’s fastest-growing stock exchanges. Investors may be also interested to check Brasil Pharma SA liquidity at the market.

More notable recent Brasil Pharma SA (BVMF:BPHA3) news were published by: Reuters.com which released: “Brasil Pharma nears sale of two drugstore chains, sources say” on September 07, 2016, also Reuters.com with their article: “Brazil’s Extrafarma enters talks to buy Brasil Pharma unit -report” published on June 17, 2016, Reuters.com published: “Brazil’s Ultrapar talks to buy Big Ben drugstore chain collapse: sources” on December 28, 2016. More interesting news about Brasil Pharma SA (BVMF:BPHA3) were released by: Therealdeal.com and their article: “Buyer revealed: Brazilian pharmaceutical exec pays $14M for Miami Beach home” published on May 27, 2016 as well as Reuters.com‘s news article titled: “BTG Pactual-backed BR Pharma to move ahead with capital plan” with publication date: December 07, 2015.

Brasil Pharma SA is a Brazil-based company engaged primarily in the pharmaceutical retail sector. The company has market cap of $574.45 million. The Company’s main business activity is selling medicine, perfumeries, cosmetics, dermocosmetics, personal care and beauty products in retail. It currently has negative earnings. The Company’s activities are divided into own transactions and franchise chain transactions.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com